Results 281 to 290 of about 589,499 (392)
(+)‐Dinapsoline: An Efficient Synthesis and Pharmacological Profile of a Novel Dopamine Agonist. [PDF]
Sing‐Yuen Sit, NULL AUTHOR_ID
openalex +1 more source
Psilocybin as a novel treatment for chronic pain
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey+3 more
wiley +1 more source
In Vivo Evidence that 5-HT2C Receptor Antagonist but not Agonist Modulates Cocaine-Induced Dopamine Outflow in the Rat Nucleus Accumbens and Striatum [PDF]
Sylvia Navailles+3 more
openalex +1 more source
Abstract Background and Purpose Preclinical studies suggest that highly selective dopamine D3 receptor (D3R) antagonists or partial agonists hold promise for treating substance use disorders. However, their limited effectiveness in reducing cocaine self‐administration is a major drawback.
Omar Soler‐Cedeño+9 more
wiley +1 more source
Impulse control and related behavioral disorders (ICRD) in Idiopathic Parkinson's Disease treated with different dopamine agonists in Hong Kong: Is any dopamine agonist better? [PDF]
Wu HF+10 more
europepmc +1 more source
Relevance of state–behaviour feedbacks for animal welfare
ABSTRACT An animal's behaviour and its state, including its health and affective state, are dynamic and tightly coupled, influencing each other over time. Although both are relevant to the animal's welfare, there has been limited research on their dynamics in welfare studies. Here we aim to: (i) review evidence for feedbacks between state and behaviour
Camille M. Montalcini+2 more
wiley +1 more source
Circadian Phase-Dependent Modulation of cGMP-Gated Channels of Cone Photoreceptors by Dopamine and D2 Agonist [PDF]
Gladys Y.‐P. Ko+2 more
openalex +1 more source
Treatment of social phobia with the dopamine agonist pergolide
Gerardo Villarreal+4 more
openalex +1 more source
ABSTRACT Objective Managing gastrointestinal symptoms in patients with phaeochromocytoma and paraganglioma (PPGL) is challenging due to the risk of catecholaminergic crisis with many commonly prescribed medications, especially in functional tumours.
Monica Majumder+5 more
wiley +1 more source